Matches in Wikidata for { <http://www.wikidata.org/entity/Q57696063> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q57696063 description "article scientifique publié en 1997" @default.
- Q57696063 description "article" @default.
- Q57696063 description "im November 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57696063 description "wetenschappelijk artikel" @default.
- Q57696063 description "наукова стаття, опублікована в листопаді 1997" @default.
- Q57696063 description "հոդված" @default.
- Q57696063 name "OP5. Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone resistant prostate cancer based on a Canadian randomised trial with palliative endpoints" @default.
- Q57696063 name "OP5. Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone resistant prostate cancer based on a Canadian randomised trial with palliative endpoints" @default.
- Q57696063 type Item @default.
- Q57696063 label "OP5. Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone resistant prostate cancer based on a Canadian randomised trial with palliative endpoints" @default.
- Q57696063 label "OP5. Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone resistant prostate cancer based on a Canadian randomised trial with palliative endpoints" @default.
- Q57696063 prefLabel "OP5. Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone resistant prostate cancer based on a Canadian randomised trial with palliative endpoints" @default.
- Q57696063 prefLabel "OP5. Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone resistant prostate cancer based on a Canadian randomised trial with palliative endpoints" @default.
- Q57696063 P1433 Q57696063-DF1A1269-762A-4CE5-B85E-C6225DCFDB8E @default.
- Q57696063 P1476 Q57696063-420E9342-B226-4B99-AC34-1E033B5FD403 @default.
- Q57696063 P2093 Q57696063-55957C79-3AD3-4D7C-A0DB-96DA3C48D8F5 @default.
- Q57696063 P2093 Q57696063-6520B534-014F-4835-BA58-1DE63E3B4B60 @default.
- Q57696063 P2093 Q57696063-8ACC4A3A-EB60-4B99-AEF2-C5B2AC0DE231 @default.
- Q57696063 P304 Q57696063-4B2CDC0B-3619-4974-A67B-B6D8C203C50B @default.
- Q57696063 P31 Q57696063-DB1C4FFC-CEA3-4714-B74C-55B292257C07 @default.
- Q57696063 P356 Q57696063-D1494C10-2827-41E8-B97C-4F5F8165094D @default.
- Q57696063 P478 Q57696063-4295A1E7-FBDA-4334-8FC8-1783757F4A7C @default.
- Q57696063 P50 Q57696063-17D48093-1AF5-4C99-BDB7-4087E072A8B0 @default.
- Q57696063 P577 Q57696063-8827B2C6-E3FB-4125-B528-124A9A5A1B6D @default.
- Q57696063 P921 Q57696063-4C80B68F-9EBC-4E5B-B4E3-9C703F67A896 @default.
- Q57696063 P356 S0959-8049(97)85884-4 @default.
- Q57696063 P1433 Q332260 @default.
- Q57696063 P1476 "OP5. Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone resistant prostate cancer based on a Canadian randomised trial with palliative endpoints" @default.
- Q57696063 P2093 "AR Willan" @default.
- Q57696063 P2093 "DJ Bloomfield" @default.
- Q57696063 P2093 "MD Krahn" @default.
- Q57696063 P304 "S2" @default.
- Q57696063 P31 Q13442814 @default.
- Q57696063 P356 "10.1016/S0959-8049(97)85884-4" @default.
- Q57696063 P478 "33" @default.
- Q57696063 P50 Q106114426 @default.
- Q57696063 P577 "1997-11-01T00:00:00Z" @default.
- Q57696063 P921 Q974135 @default.